Lucid Diagnostics (LUCD) Cash from Financing Activities (2020 - 2026)

Lucid Diagnostics' Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $5.5 million for Q1 2026.

• Quarterly Cash from Financing Activities fell 64.46% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.1 million (up 8.67% YoY) and the FY2025 annual result came in at $59.0 million, up 22.34% from the prior year.
• Cash from Financing Activities was $5.5 million for Q1 2026 at Lucid Diagnostics, up from $2000.0 in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $27.1 million in Q3 2025 and bottomed at $1000.0 in Q4 2022.
• A 5-year average of $9.1 million and a median of $5.2 million in 2023 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 100.0% — and 2023, when it soared 499900.0%.
• Lucid Diagnostics' Cash from Financing Activities stood at $1000.0 in 2022, then surged by 499900.0% to $5.0 million in 2023, then soared by 259.98% to $18.0 million in 2024, then sank by 99.99% to $2000.0 in 2025, then surged by 274250.0% to $5.5 million in 2026.
• Business Quant data shows LUCD's Cash from Financing Activities at $5.5 million in Q1 2026, $2000.0 in Q4 2025, and $27.1 million in Q3 2025.